Literature DB >> 26981940

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Bernard Zinman, John M Lachin, Silvio E Inzucchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26981940     DOI： 10.1056/NEJMc1600827

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  77 in total

Review 1.  Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field.

Authors:  Natasha Dave; Jiao Wu; Sandhya Thomas
Journal:  Curr Diab Rep       Date:  2018-06-08       Impact factor: 4.810

Review 2.  Progress in heart failure treatment in Germany.

Authors:  Mark Luedde; Martina E Spehlmann; Norbert Frey
Journal:  Clin Res Cardiol       Date:  2018-07-02       Impact factor: 5.460

3.  Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: A Focus on Heart Failure.

Authors:  Nisha Bansal
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-15       Impact factor: 8.237

4.  Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support.

Authors:  Sung Eun Choi; Seth A Berkowitz; John S Yudkin; Huseyin Naci; Sanjay Basu
Journal:  Med Decis Making       Date:  2019-02-15       Impact factor: 2.583

Review 5.  Pharmacologic Management for Heart Failure and Emerging Therapies.

Authors:  Diana H Kim; Feng-Ju Chien; Howard J Eisen
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

6.  Investigation of expression and influence of CTGF and HO-1 in rats with diabetic retinopathy.

Authors:  Yongjian Huang; Chaoxu Qian; Jilin Zhou; Jinsong Xue
Journal:  Exp Ther Med       Date:  2019-12-30       Impact factor: 2.447

Review 7.  Obesity medications in development.

Authors:  Candida J Rebello; Frank L Greenway
Journal:  Expert Opin Investig Drugs       Date:  2019-12-19       Impact factor: 6.206

8.  Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults.

Authors:  Anum Saeed; Vijay Nambi; Wensheng Sun; Salim S Virani; George E Taffet; Anita Deswal; Elizabeth Selvin; Kunihiro Matsushita; Lynne E Wagenknecht; Ron Hoogeveen; Josef Coresh; James A de Lemos; Christie M Ballantyne
Journal:  J Am Coll Cardiol       Date:  2018-03-10       Impact factor: 24.094

9.  Co-administration of a konjac-based fibre blend and American ginseng (Panax quinquefolius L.) on glycaemic control and serum lipids in type 2 diabetes: a randomized controlled, cross-over clinical trial.

Authors:  Alexandra L Jenkins; Linda M Morgan; Jacqueline Bishop; Elena Jovanovski; David J A Jenkins; Vladimir Vuksan
Journal:  Eur J Nutr       Date:  2017-07-07       Impact factor: 5.614

10.  Renal olfactory receptor 1393 contributes to the progression of type 2 diabetes in a diet-induced obesity model.

Authors:  Blythe D Shepard; Hermann Koepsell; Jennifer L Pluznick
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.